The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
CARDIFF ONCOLOGY INC COM 14147L108 9,200 1,383,500 SH   SOLE 1 1,383,500 0 0
COINBASE GLOBAL INC COM CL A 19260Q107 10,132 40,000 SH   SOLE 1 40,000 0 0
CRISPR THERAPEUTICS AG NAMEN AKT H17182108 3,238 20,000 SH   SOLE 1 20,000 0 0
CUE BIOPHARMA INC COM 22978P106 17,323 1,486,986 SH   SOLE 1 1,486,986 0 0
DIAMEDICA THERAPEUTICS INC COM NEW 25253X207 906 203,641 SH   SOLE 1 203,641 0 0
HIMAX TECHNOLOGIES INC SPONSORED ADR 43289P106 3,332 200,000 SH   SOLE 1 200,000 0 0
IRIDIUM COMMUNICATIONS INC COM 46269C102 3,199 80,000 SH   SOLE 1 80,000 0 0
KRATOS DEFENSE & SEC SOLUTIO COM NEW 50077B207 7,856 275,738 SH   SOLE 1 275,738 0 0
LANTERN PHARMA INC COM 51654W101 9,583 656,364 SH   SOLE 1 656,364 0 0
MAXAR TECHNOLOGIES INC COM 57778K105 76,660 1,920,333 SH   SOLE 1 1,920,333 0 0
MP MATERIALS CORP COM CL A 553368101 4,055 110,000 SH   SOLE 1 110,000 0 0
QUANTUMSCAPE CORP COM CL A 74767V109 9,870 337,316 SH   SOLE 1 337,316 0 0
REATA PHARMACEUTICALS INC CL A 75615P103 10,065 71,115 SH   SOLE 1 71,115 0 0
REPLIMUNE GROUP INC COM 76029N106 17,284 449,879 SH   SOLE 1 449,879 0 0
ROBLOX CORP CL A 771049103 2,699 30,000 SH   SOLE 1 30,000 0 0